Affiliation:
1. Certara Canterbury UK
2. University of Leiden Leiden The Netherlands
Subject
Pharmacology (medical),Pharmacology
Reference6 articles.
1. ICH E14/S7B draft guideline: clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmic potential question and answers (2020). Accessed December 13 2020.
2. General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy;Li Z.;Clin. Pharmacol. Ther.,2020
3. Utility of normalized TdP score system in drug proarrhythmic potential assessment: a blinded in vitro study of CiPA drugs;Liu T.;Clin. Pharmacol. Ther.
4. Time for a fully integrated nonclinical‐clinical risk assessment to streamline QT prolongation liability determinations: a pharma industry perspective;Vargas H.M.;Clin. Pharmacol. Ther.,2021
5. Translational models and tools to reduce clinical trials and improve regulatory decision‐making for QTc and proarrhytmia risk (ICH E14/S7B updates);Strauss D.G.;Clin. Pharmacol. Ther.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献